drugset / Trial / NCT02848417

Glutathione vs. Curcumin Clinical Trial

NCT02848417

RandomizedParallel-groupDouble-blindTreatment

Summary

The investigator proposes to perform a phase I/II study comparing two nutraceuticals and placebo that target mediators identified in the investigator's prior dynamic modeling study of Gulf War Illness (GWI). The investigator will repeat the dynamic modeling before treatment and on therapy to assess the modeling and the impact of the interventions on the homeostatic networks that have identified, with an added focus on the glutathione/redox system.

Timeline

Start
2016-04
Primary completion
2019-08
Completion
2020-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 400 mg Oral
Subject Glutathione Peptide 630 mg Oral

Indications